vimarsana.com
Home
Live Updates
Ipsen : Completes Acquisition of Clementia Pharmaceuticals -Today at 11:00 am : comparemela.com
Ipsen : Completes Acquisition of Clementia Pharmaceuticals -Today at 11:00 am
Ipsen's Rare Diseases portfolio significantly enhanced with late-stage drug candidate, palovarotene, for the treatment of rare bone disorders
in adult and pediatric patients
...
Related Keywords
Quebec ,
Canada ,
Paris ,
France General ,
France ,
Saclay ,
United Kingdom ,
Cambridge ,
Cambridgeshire ,
United States ,
American ,
Ipsen Euronext ,
Alexandre Lebeaut ,
Clarissa Desjardins ,
Roche Pharmaceuticals ,
Clementia Pharmaceuticals ,
Quebec Superior Court ,
Drug Administration ,
European Medicines Agency ,
Clementia Pharmaceuticals Inc ,
Rare Diseases ,
Quebec Superior ,
Chief Scientific Officer ,
Chief Executive Officer ,
Fibrodysplasia Ossificans Progressiva ,
Multiple Osteochondromas ,
Orphan Drug ,
Fast Track ,
Breakthrough Therapy ,
Rare Pediatric Disease ,
Consumer Healthcare ,
Sponsored Leveli American Depositary Receipt ,
Ped Trial ,
French Autorit ,
Des March ,
Markets ,
comparemela.com © 2020. All Rights Reserved.